Lexicon Pharmaceuticals Inc (LXRX)

Oct 18, 2025

Is Lexicon Pharmaceuticals Inc. stock attractive for hedge fundsSwing Trade & Daily Price Action Insights - newser.com

Oct 18, 2025

Oct 18, 2025

Is Lexicon Pharmaceuticals Inc. building a consolidation baseWeekly Trend Summary & Low Risk Entry Point Guides - newser.com

Oct 18, 2025

Oct 18, 2025

Is Lexicon Pharmaceuticals Inc. stock a defensive play in 20252025 Market Overview & Comprehensive Market Scan Reports - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Oct 17, 2025

How analysts rate Lexicon Pharmaceuticals Inc. stock todayJuly 2025 EndofMonth & Community Trade Idea Sharing - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025

Oct 17, 2025

Lexicon Pharmaceuticals Inc Stock Analysis and ForecastSector Leadership Analysis & Affordable Growth Strategies - earlytimes.in

Oct 17, 2025

Oct 14, 2025

Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit - The Manila Times

Oct 14, 2025

Oct 14, 2025

Short interest data insights for Lexicon Pharmaceuticals Inc.2025 Geopolitical Influence & AI Enhanced Trading Signals - newser.com

Oct 14, 2025

Oct 10, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8% HigherWhat's Next? - MarketBeat

Oct 10, 2025

Oct 10, 2025

Lexicon Pharmaceuticals' (LXRX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 08, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Down 6.3%Time to Sell? - MarketBeat

Oct 08, 2025

Oct 08, 2025

Lexicon (LXRX) Engages in Policy Discussion to Tackle Chronic Pa - GuruFocus

Oct 08, 2025

Oct 08, 2025

Lexicon Pharmaceuticals Hosts Roundtable on Legislative Solutions for Chronic Pain Management - Quiver Quantitative

Oct 08, 2025

Oct 08, 2025

Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People with Chronic Pain - MarketScreener

Oct 08, 2025

Oct 08, 2025

Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People With Chronic Pain - 富途牛牛

Oct 08, 2025

Oct 06, 2025

Detecting price anomalies in Lexicon Pharmaceuticals Inc. with AIEarnings Beat & Intraday High Probability Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Can you recover from losses in Lexicon Pharmaceuticals Inc.2025 Analyst Calls & Safe Entry Point Identification - newser.com

Oct 05, 2025

Oct 05, 2025

Is Lexicon Pharmaceuticals Inc. a candidate for recovery playPortfolio Value Summary & Consistent Income Trade Recommendations - newser.com

Oct 05, 2025

Oct 04, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Oct 04, 2025

Oct 03, 2025

Is Lexicon Pharmaceuticals Inc. stock bottoming out2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com

Oct 03, 2025

Oct 03, 2025

What’s the recovery path for long term holders of Lexicon Pharmaceuticals Inc.Portfolio Return Summary & Long-Term Capital Growth Ideas - newser.com

Oct 03, 2025

Oct 03, 2025

Smart tools for monitoring Lexicon Pharmaceuticals Inc.’s price actionGap Up & High Accuracy Investment Signals - newser.com

Oct 03, 2025

Oct 02, 2025

Revenues Not Telling The Story For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) After Shares Rise 28% - simplywall.st

Oct 02, 2025

Sep 30, 2025

Lexicon Pharmaceuticals, Inc. $LXRX Stake Reduced by Goldman Sachs Group Inc. - MarketBeat

Sep 30, 2025

Sep 28, 2025

What analysts say about Lexicon Pharmaceuticals Inc stockContrarian Investment Ideas & Big Gains Low Budget - earlytimes.in

Sep 28, 2025

Sep 26, 2025

Lexicon reports FDA's decision to extend review period for Zynquista - MSN

Sep 26, 2025

Sep 24, 2025

Lexicon Pharmaceuticals, Inc. $LXRX Shares Purchased by Compagnie Lombard Odier SCmA - MarketBeat

Sep 24, 2025